ArticleCellular oncology (Dordrecht, Netherlands)2023

ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.

Linhua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.